Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 2,491 |
|
|||||
| News | (4) | ||||||
| Day High | 9.98 | Low High |
|||||
| Day Low | 9.60 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aeterna Zentaris Inc | AEZS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.23 | -2.32% | 9.70 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 9.98 | 9.60 | 9.98 | 9.69 | 9.93 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 68 | 2,491 | US$ 9.82 | US$ 24,452 | - | 1.3601 - 11.10 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:04:02 | formt | 100 | US$ 9.70 | USD |
Aeterna Zentaris Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 47.05M | 4.86M | - | 4.5M | -16.55M | -3.41 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aeterna Zentaris News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AEZS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.36 | 11.10 | 8.36 | 9.99 | 51,226 | 1.34 | 16.03% |
| 1 Month | 7.80 | 11.10 | 7.74 | 9.28 | 18,274 | 1.90 | 24.36% |
| 3 Months | 1.88 | 11.10 | 1.85 | 4.20 | 20,127 | 7.82 | 415.96% |
| 6 Months | 2.06 | 11.10 | 1.68 | 3.22 | 16,775 | 7.64 | 370.87% |
| 1 Year | 2.78 | 11.10 | 1.3601 | 2.92 | 13,416 | 6.92 | 248.92% |
| 3 Years | 0.901 | 11.10 | 0.1645 | 0.65218 | 533,318 | 8.80 | 976.58% |
| 5 Years | 2.95 | 11.10 | 0.1645 | 1.14 | 1,846,464 | 6.75 | 228.81% |
Aeterna Zentaris Description
| AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland. |
